tradingkey.logo
tradingkey.logo
Buscar

AVITA Medical Inc

RCEL
Añadir a la lista de seguimiento
5.060USD
+0.390+8.35%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
778.65MCap. mercado
PérdidaP/E TTM

Más Datos de AVITA Medical Inc Compañía

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.

Información de AVITA Medical Inc

Símbolo de cotizaciónRCEL
Nombre de la empresaAVITA Medical Inc
Fecha de salida a bolsaMar 18, 2012
Director ejecutivoVance (Cary G)
Número de empleados260
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 18
Dirección28159 Avenue Stanford
CiudadVALENCIA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal91355
Teléfono16613679170
Sitio Webhttps://www.avitamedical.com/
Símbolo de cotizaciónRCEL
Fecha de salida a bolsaMar 18, 2012
Director ejecutivoVance (Cary G)

Ejecutivos de AVITA Medical Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
46.93K
-6.37%
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
39.84K
-7.51%
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Ms. Nicole Linda Kelsey, J.D.
Ms. Nicole Linda Kelsey, J.D.
Chief Legal and Compliance Officer, Corporate Secretary
Chief Legal and Compliance Officer, Corporate Secretary
--
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
46.93K
-6.37%
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
39.84K
-7.51%
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de AVITA Medical Inc?

Los cinco principales accionistas de AVITA Medical Inc son: Prof. Suzanne Crowe

¿Cuántas instituciones poseen acciones de AVITA Medical Inc (RCEL)?

A fecha de 2026Q1, 209 instituciones poseen acciones de AVITA Medical Inc, con un valor de mercado combinado de aproximadamente 6.52M, lo que representa el 21.20% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -1392153.00.